Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:58 PM
NCT ID:
NCT02292758
Group ID:
EG000
Title:
Arm I (Irinotecan, Cetuximab, Bevacizumab)
Description:
Patients receive 500 mg/m\^2 cetuximab IV over 90-120 minutes, 5 mg/kg bevacizumab IV over 30-90 minutes, and 180 mg/m\^2 irinotecan IV over 90 minutes on day 1. Cycles repeat every 14 days in the absence of disease progression or unacceptable toxicity.
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
19
Other Number Affected:
19
Other Number At Risk:
19
Study:
NCT02292758
Results Section:
NCT02292758
Adverse Events Module:
NCT02292758